Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Martel

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
American Journal of Clinical Dermatology|October 21, 2025
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III TrialsTiffany Mayo, Jonathan I Silverberg, April Armstrong, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2025
Neutralizing IL-22RA1 improves histologic and molecular alterations associated with atopic dermatitis pathogenesisSophia Wasserer, Thomas Litman, Josephine Hebsgaard, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometriumF Labrie, C Labrie, A Bélanger, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
American Journal of Clinical Dermatology|October 21, 2025
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III TrialsTiffany Mayo, Jonathan I Silverberg, April Armstrong, et al.
The Journal of Allergy and Clinical Immunology|November 13, 2025
Neutralizing IL-22RA1 improves histologic and molecular alterations associated with atopic dermatitis pathogenesisSophia Wasserer, Thomas Litman, Josephine Hebsgaard, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometriumF Labrie, C Labrie, A Bélanger, et al.
Pageof 12